Literature DB >> 27051147

Peritonitis due to Streptococcus gordonii in a patient treated with continuous ambulatory peritoneal dialysis.

S Maraki1, A Papadopoulou1, E Nioti1, K Perakis2.   

Abstract

Entities:  

Year:  2016        PMID: 27051147      PMCID: PMC4795438          DOI: 10.4103/0971-4065.168144

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN: 0971-4065


× No keyword cloud information.
Sir, Peritonitis is a serious complication of peritoneal dialysis (PD).[1] It is the main cause of technique failure, peritoneal catheter loss and transfer to hemodialysis with increased health care costs.[2] Gram-positive cocci (GPC) account for over half of the PD episodes with Staphylococcus species being the most commonly encountered.[1] Streptococci are generally rare causes of continuous ambulatory PD (CAPD) peritonitis.[3] We describe a case of PD-related peritonitis caused by Streptococcus gordonii. A 70-year-old female with end-stage renal disease secondary to chronic pyelonephritis had been on CAPD for 12 years. She was admitted to our unit with a 2-day history of abdominal pain, nausea, fever, and cloudy dialysate. The patient had no recent history of invasive dental procedures, but she had poor dental hygiene. On examination, she was afebrile and diffuse abdominal tenderness was noted. The catheter exit site was clean and there were no signs of tunnel infection. The white blood cell (WBC) count in the peritoneal fluid was 5,160/mm3 (90% neutrophils). A Gram-stain of the centrifuged dialysis effluent revealed only numerous leucocytes; no microorganisms were seen. She was diagnosed to have CAPD peritonitis and empirical treatment with intraperitoneal vancomycin and amikacin was initiated according to our protocol. Culture of the dialysis effluent yielded a pure growth of S. gordonii. The isolate was sensitive to penicillin, ampicillin, cefuroxime, cefotaxime, ceftriaxone, ceftazidime, cefepime, linezolid, daptomycin, and vancomycin, but resistant to erythromycin. After 5 days of antimicrobial therapy, the peritoneal fluid WBC count decreased to normal limits and cultures were negative. The patient was discharged in stable condition 1 week after her admission and antibiotic treatment was continued for a total of 2 weeks. Streptococcus viridans are commensal species that normally reside the oral cavity and show relatively weak or no pathogenicity. However, they have the potential to invade sterile body sites and cause life-threatening infections. Streptococci of the viridans group account for the majority of streptococcal PD-related peritonitis.[3] S. gordonii is associated with endocarditis, arthritis, extensive multiple subcutaneous abscesses, and spontaneous peritonitis. Another case of PD-related peritonitis caused by S. gordonii has been previously described.[4] In our patient, the exact source of S. gordonii could not be ascertained. We presume that the infection was caused by direct inoculation of bacteria through the peritoneal catheter into the peritoneal fluid during PD exchange. The oral cavity is the most probable source of the infection. In a recent study, the investigators found that contamination during exchange constituted the most common cause of viridans streptococcal PD-related peritonitis.[3] Figueiredo et al. comparing peritonitis episodes in patients using and not using a mask during PD exchanges showed that peritonitis due to S. viridans was detected only in the group without masks.[5] This finding demonstrated that the oral cavity is the most likely source of S. viridans. In conclusion, although rarely encountered, S. gordonii should be kept in mind as a cause of CAPD peritonitis that can be treated successfully with early recognition and appropriate antibiotic therapy.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Peritonitis prevention in CAPD: to mask or not?

Authors:  A E Figueiredo; C E Poli de Figueiredo; D O d'Avila
Journal:  Perit Dial Int       Date:  2000 May-Jun       Impact factor: 1.756

2.  Streptococcus gordonii peritonitis in a patient on CAPD.

Authors:  Chi Yuen Cheung; Naomi H Y Cheng; Ka Foon Chau; Chun Sang Li
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

3.  Peritonitis influences mortality in peritoneal dialysis patients.

Authors:  L F Fried; J Bernardini; J R Johnston; B Piraino
Journal:  J Am Soc Nephrol       Date:  1996-10       Impact factor: 10.121

4.  Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area.

Authors:  Bayode Afolalu; Laura Troidle; Osasu Osayimwen; Jaya Bhargava; Jenny Kitsen; Fredric O Finkelstein
Journal:  Perit Dial Int       Date:  2009 May-Jun       Impact factor: 1.756

5.  Viridans streptococci in peritoneal dialysis peritonitis: clinical courses and long-term outcomes.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.